ChemoMetec A/S (CPH:CHEMM)
Denmark · Delayed Price · Currency is DKK 569.00
-7.00 (-1.22%)
Oct 16, 2026, 4:59 PM CET
ChemoMetec Market Cap
ChemoMetec has a market cap or net worth of 9.79 billion as of October 16, 2026. It is the 8,116th most valuable company in the world and the 39th biggest in Denmark. Its market cap has decreased by 13.14% in one year.
Market Cap
9.79B
Enterprise Value
9.50B
Revenue
511.06M
Global Rank
Country Rank
#39 Denmark
PE Ratio
49.05
ChartMarket Cap Chart
Since December 18, 2006, ChemoMetec's market cap has increased from 374.48M to 9.79B, an increase of 2,513.54%. That is a compound annual growth rate of 17.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 9.79B | -18.20% |
| Dec 30, 2025 | 11.96B | 41.40% |
| Dec 30, 2024 | 8.46B | 25.31% |
| Dec 29, 2023 | 6.75B | -43.81% |
| Dec 30, 2022 | 12.02B | -17.11% |
| Dec 30, 2021 | 14.50B | 44.12% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.17T |
| Genmab | 151.12B |
| Coloplast | 105.49B |
| Demant | 75.71B |
| H. Lundbeck | 46.83B |
| Ambu A/S | 20.35B |
| Bavarian Nordic | 18.09B |
| Zealand Pharma | 15.63B |